What is the significance of evaluating estradiol (estrogen), Follicle-Stimulating Hormone (FSH), and Luteinizing Hormone (LH) levels in a male patient with an empty sella syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hormonal Evaluation in Male Patients with Empty Sella

In a male patient with empty sella, measuring estradiol, FSH, and LH is essential to detect secondary hypogonadism, which occurs in 18.75-50% of cases, with complete empty sella carrying significantly higher risk than partial empty sella. 1

Clinical Significance and Diagnostic Rationale

Why These Hormones Matter

  • FSH and LH measurement distinguishes primary from secondary (pituitary-hypothalamic) hypogonadism, which is critical when empty sella is present, as the compressed pituitary gland may cause hypopituitarism 2

  • Low FSH and LH with low testosterone confirms hypogonadotropic hypogonadism, the characteristic pattern seen in empty sella-related pituitary dysfunction 1, 3

  • Estradiol measurement in males is specifically indicated when evaluating testosterone deficiency with breast symptoms or gynecomastia, though in empty sella patients, the primary concern is detecting hypogonadism rather than elevated estradiol 4

Expected Patterns in Empty Sella

Complete empty sella (≥50% CSF filling, pituitary <2mm) shows significantly higher rates of secondary adrenal insufficiency (p=0.021) and secondary hypogonadism (p=0.041) compared to partial empty sella. 1

  • Secondary hypogonadism occurs in 18.75-50% of primary empty sella cases, making gonadotropin evaluation mandatory 1, 5, 6

  • The typical hormonal pattern shows low LH, low FSH, and low testosterone, as demonstrated in case reports where LH was 0.3-0.9 mIU/ml (normal 2.2-8.4), FSH was 1.5-1.7 mIU/ml (normal 1.8-12), and testosterone was 0.05-86.6 ng/dl (normal 225-1,039) 3, 7

  • GnRH stimulation testing reveals blunted LH and FSH responses, confirming pituitary-level dysfunction rather than hypothalamic pathology 3

Comprehensive Hormonal Workup Algorithm

Initial Laboratory Panel

All patients with empty sella require complete pituitary axis evaluation regardless of symptoms, as affected-axis rates often exceed 10% and may reach 50%. 1

  • Morning total testosterone, FSH, and LH form the basic hormonal workup for evaluating the gonadotropic axis 2

  • Prolactin measurement is necessary to exclude hyperprolactinemia as a reversible cause of secondary hypogonadism, which occurs in 18.75-20.8% of empty sella cases 2, 5, 6

  • Morning cortisol and ACTH should be measured, as secondary adrenal insufficiency occurs in 62.5% of cases 5

  • TSH and free T4 are essential, as secondary hypothyroidism occurs in 50% of cases 5

  • IGF-1 and consideration of GH stimulation testing, as GH deficiency occurs in 12.5% of cases 5, 6

Estradiol-Specific Considerations

  • Estradiol measurement using LC-MS/MS is the reference standard for accurate assessment in males, though routine measurement is only recommended when breast symptoms or gynecomastia are present 4

  • In obese men with empty sella, increased aromatization of testosterone to estradiol in adipose tissue causes estradiol-mediated negative feedback that suppresses pituitary LH secretion, potentially compounding pituitary dysfunction 2, 8

  • Elevated baseline estradiol measurements warrant endocrinology referral for further evaluation 4

Clinical Implications and Management

When Hypogonadism is Confirmed

If free testosterone is frankly low on two separate morning assessments with low LH/FSH, further evaluation must include prolactin, iron saturation, complete pituitary function testing, and MRI confirmation of the empty sella. 2

  • For fertility preservation, testosterone replacement should NOT be prescribed, as it suppresses spermatogenesis 8

  • Selective estrogen receptor modulators like clomiphene citrate or hCG therapy may stimulate endogenous testosterone production while preserving fertility, with documented restoration of ejaculation and testicular volume within 3-6 months 8, 3, 7

  • Cabergoline therapy for hyperprolactinemia-associated hypogonadism can normalize hormone levels, semen parameters, and clinical symptoms within 4 months, with documented spontaneous conception 7

Monitoring for Multiple Deficiencies

The proportion of cases with two or more affected pituitary axes is significantly higher in complete empty sella (p=0.010). 1

  • Secondary hypothyroidism is significantly more common among males (p=0.001), requiring particular vigilance 1

  • Posterior pituitary involvement occurs in 12.5% of cases, necessitating evaluation for diabetes insipidus if polyuria or polydipsia are present 5

Critical Pitfalls to Avoid

  • Do not assume empty sella is merely an incidental finding—the high incidence of endocrine abnormalities (50-62.5%) mandates prompt hormonal evaluation 5, 6

  • Do not rely on FSH levels alone to predict spermatogenesis in azoospermic patients, as men with maturation arrest can have normal FSH and testicular volume 2

  • Do not use standard immunoassays for estradiol measurement in males—LC-MS/MS provides superior accuracy and specificity 4

  • Do not initiate testosterone replacement without confirming low free testosterone on two separate occasions and completing the hypogonadism workup to exclude reversible causes like hyperprolactinemia 2, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Estradiol Measurement in Men

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Study of prevalence of endocrine abnormalities in primary empty sella.

Indian journal of endocrinology and metabolism, 2013

Research

Empty sella syndrome - beyond being an incidental finding.

Indian journal of endocrinology and metabolism, 2012

Research

[Infertility Due to Hyperprolactinemia in Empty Sella : A Case Report].

Hinyokika kiyo. Acta urologica Japonica, 2019

Guideline

Management of Low Free Testosterone with Normal Total Testosterone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the diagnosis and treatment for partial empty sella syndrome?
What hormones should be checked in a case of empty sella syndrome?
What is the management approach for a patient with empty sella syndrome?
What is the significance of an empty sella in a patient with low testosterone levels, normal FSH (Follicle-Stimulating Hormone), LH (Luteinizing Hormone), and prolactin levels, and no overt pituitary lesion on MRI (Magnetic Resonance Imaging)?
Can patients with hypothyroidism have an empty sella or partially empty sella?
What should be the next steps for an elderly man with rising Prostate-Specific Antigen (PSA) levels?
What is the expected range of serum estradiol levels on day 3 of Menopur (menotropin) treatment in a woman undergoing fertility treatment?
What is the management plan for a patient with a Thyroid-Stimulating Hormone (TSH) level of 6.5 who has started on thyroxine (levothyroxine) therapy?
How long should an adult patient with chronic rhinosinusitis and rhinitis medicamentosa stop using topical nasal decongestants like oxymetazoline (nasal decongestant) to improve their condition?
What is the most appropriate management for a patient with a pelvic fracture, large hematoma, active bleeding, and hypotension after a motor vehicle accident (MVA)?
What is the interpretation and management of a decreased PEF25-75 (Peak Expiratory Flow 25-75) value in a patient with respiratory symptoms or known respiratory diseases such as asthma or Chronic Obstructive Pulmonary Disease (COPD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.